Anabrez
is a medicine used to treat breast cancer. It belongs to the class of medications known as aromatase inhibitors, which inhibit the enzyme aromatase, which converts androgens into estrogen. Anabrez inhibits this process, lowering estrogen levels in the body and slowing or stopping the proliferation of hormone receptor-positive breast cancer cells. Anabrez is usually given to postmenopausal women with hormone receptor-positive breast cancer, either as a first-line treatment or in combination with other drugs such as chemotherapy or targeted therapy. It is frequently used as an adjuvant treatment, following tumor removal surgery, to help prevent cancer from recurring. Anabrez may cause hot flashes, joint pain, weariness, and nausea. More serious side effects may include bone loss, which raises the risk of fractures, as well as an increased risk of developing cardiovascular problems. Before beginning Anabrez treatment, you should consult your doctor about the potential advantages and hazards. They can advise whether Anabrez is the best option for your situation and medical history. Regular monitoring and follow-up appointments will also be required to evaluate the treatment's effectiveness and manage any side effects that may occur.
